NXTM: NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance - Revenue Increases to $79.5 million, up 10% from Q1'14 - Home Revenue Increases to $43.5 million, up 19% from Q1'14 - Company Trending Toward Higher End of Annual Revenue Guidance Range
The company has been aggressively opening dialysis clinics featuring their NxStage System 1 machines. A smart way (in my opinion) to generate both product sales and ensure use of product. They continue to lose money, but the numbers suggest to me that they may break even in about 6 quarters, if they continue to generate the kind of outpatient ctr. revenue that they have to this point (and open some more centers.)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.